Can you plateau on Wegovy?
Indeed you can. You can plateau on Wegovy, and a plateau does not mean you have failed or that the medicine has no effect. Wegovy contains semaglutide and is licensed as an adjunct to a reduced-calorie diet and increased physical activity for weight management in eligible adults. It acts on appetite pathways that can help you feel fuller and less hungry, but it does not remove the normal biology of weight loss. [1,2]
As weight falls, the body usually needs fewer calories to maintain its new size. The same meals, snacks, alcohol intake or activity level that worked earlier in treatment may therefore stop producing the same deficit. In the STEP 5 trial information reported in the Wegovy SmPC, mean body weight decreased from baseline to week 68 and then plateaued, with average weight loss maintained to week 104. [2]
A plateau is best judged from the trend, not a single weigh-in. Fluid retention, constipation, menstrual cycle changes, salty meals, travel, stress and different weighing conditions can hide fat loss for days or weeks. A four-week weight trend is usually more useful than one disappointing reading.
Why weight loss can stall on Wegovy
A Wegovy plateau is often multi-factorial. The most common reasons include:
- Lower energy needs after weight loss: a smaller body generally uses less energy, so your previous intake may now be closer to maintenance.
- Dose stage and tolerability: some people plateau during titration, while others cannot move up because nausea, reflux, constipation or diarrhoea need managing first.
- Missed or delayed doses: irregular dosing can affect appetite control. The patient leaflet gives specific missed-dose instructions, so do not improvise a catch-up dose. [1]
- Appetite returning or feeling less dramatic: the early appetite change can feel stronger than later treatment. Less noticeable appetite suppression does not always mean there is no pharmacological effect.
- Food intake drifting upwards: liquid calories, alcohol, grazing, larger portions or higher-calorie “small” foods can quietly close the deficit.
- Activity and muscle loss: lower everyday movement and loss of lean mass can reduce energy expenditure. NICE recommends individualised diet support and physical activity goals, while the NHS advises adults to include strengthening activity at least twice weekly. [4,6]
- Side effects affecting nutrition: if nausea or constipation makes you avoid protein, fibre or fluids, your plan may become harder to sustain.
- Other health factors: sleep, stress, menopause, thyroid disease, steroids, some antidepressants and other medicines can affect appetite, water retention or weight.
Does Wegovy stop working?
People often describe Wegovy as “not working anymore” when hunger returns, the scale stops moving, weight increases slightly, or the same routine no longer gives the same results. That experience is real and worth reviewing, but it is not enough on its own to prove the medicine has stopped working.
In STEP 4, people who continued semaglutide after an initial run-in period continued to lose weight on average, while those switched to placebo regained weight on average. That does not guarantee ongoing loss for every individual, but it supports the idea that continued treatment may still be doing something even when progress feels slower. [9]
What to check before changing anything
Before assuming Wegovy has failed, work through a structured review. This is especially useful if you need information as to why you are not losing weight on Wegovy or what to do when Wegovy stops working.
- Check the trend: compare your average weight over the last four weeks, not your highest and lowest readings.
- Check your injection routine: note missed doses, late doses, storage issues or changes in injection day. Follow the patient leaflet and ask your prescriber if you are unsure. [1]
- Check your dose stage: record whether you are still titrating, on 1.7 mg, on 2.4 mg, or following a different prescriber-led plan.
- Check side effects: nausea, diarrhoea, constipation, reflux or vomiting can change what you eat and drink. Persistent or severe symptoms need clinical advice. [2,7]
- Check your food pattern: look for portion creep, alcohol, snacks, liquid calories, lower protein intake or low-fibre meals that make hunger harder to manage.
- Check movement: add or restart realistic strengthening work and everyday movement rather than relying only on hard cardio.
- Check sleep, stress and medicines: poor sleep, high stress and some medicines can change appetite, cravings, water retention or energy.
- Book a review if the plateau lasts several weeks, if you are gaining weight, if you have not lost around 5% after six months of treatment, or if side effects are making the plan hard to follow. [2,3]
Should the Wegovy dose be increased if you plateau?
Possibly, but only as a prescriber-led decision. A plateau is not a licence to take more Wegovy, take doses closer together, use more than one GLP-1 medicine, or combine Wegovy with another semaglutide product. The Wegovy SmPC says semaglutide should not be used with other GLP-1 receptor agonist products, and it gives specific rules for dose escalation, missed doses and dose timing. [2]
Current UK Wegovy product information says the usual adult maintenance dose of 2.4 mg once weekly is reached through gradual escalation over 16 weeks. It also states that, if needed for weight management in adult patients with obesity, the dose can be increased to 7.2 mg once weekly after a minimum of four weeks on 2.4 mg, using three 2.4 mg injections, with dose escalation delayed or reduced if significant gastrointestinal symptoms occur. [2]
That does not mean a higher dose is right, necessary or available for every person. The decision depends on your current dose, response, side effects, medical history, other medicines, service policy and benefit–risk review. NICE also says clinicians should consider stopping semaglutide if a person has lost less than 5% of their initial weight after six months. [3]
What to do when weight loss stalls on Wegovy
The aim is not to punish yourself into faster weight loss. The aim is to identify the most likely limiting factor and adjust safely.
For the next two weeks:
- Weigh consistently, ideally at the same time of day, and look at the weekly average.
- Keep a simple seven-day record of meals, snacks, alcohol, fluids, protein-containing foods and bowel symptoms.
- Prioritise regular meals with enough protein and fibre where tolerated. If appetite is very low or side effects are limiting food variety, ask for clinical or dietetic advice.
- Add two short resistance sessions or strengthening sessions if you are able to exercise. This can be bodyweight, bands, machines or weights; it does not need to be extreme. [6]
- Increase everyday movement in a realistic way: more walking, shorter sitting blocks, stairs, errands or gentle activity after meals.
- Reduce obvious plateau drivers first: frequent alcohol, sugary drinks, grazing, takeaways, large portions and high-calorie snacks.
- Contact your prescriber if the plateau continues, if hunger has changed sharply, if weight regain is persistent, or if dose escalation is being considered.
NICE guidance on overweight and obesity management stresses individualised support, realistic goals, behavioural strategies and regular review rather than one-size-fits-all dieting. Very restrictive diets should only be used in appropriate circumstances with proper support and supervision. [4,5]
Safety: symptoms that should not be treated as a plateau
Some symptoms need medical advice immediately. Do not explain these away as “normal Wegovy side effects” or as part of a plateau.
|
What you notice
|
Why it matters
|
What to do
|
|
Severe, persistent abdominal pain, especially if it spreads to the back or comes with vomiting
|
Possible pancreatitis has been reported with GLP-1 receptor agonists.
|
Seek urgent medical advice. If symptoms are severe, use NHS 111 or emergency care. [2,7]
|
|
Persistent vomiting or diarrhoea, dizziness, very dark urine, faintness or being unable to keep fluids down
|
Fluid loss can lead to dehydration and, rarely, deterioration in kidney function.
|
Contact your prescriber urgently or use NHS 111 if you may be dehydrated. [2,7]
|
|
Sudden loss of vision, sudden worsening vision, blurring or cloudiness, especially in one eye
|
Semaglutide has been linked with a very rare risk of non-arteritic anterior ischaemic optic neuropathy (NAION).
|
Attend eye casualty or A&E urgently. [8]
|
|
Swelling of the face, lips, tongue or throat, breathing difficulty, widespread rash or collapse
|
These can be signs of a serious allergic reaction.
|
Call 999 or seek emergency help.
|
|
Sweating, shaking, confusion, palpitations or severe weakness, especially if you use insulin or a sulfonylurea
|
The risk of hypoglycaemia can be higher when semaglutide is used with insulin or sulfonylureas.
|
Follow your diabetes plan and seek urgent help if symptoms are severe or do not improve. Contact your diabetes team or prescriber. [2]
|
What not to do during a Wegovy plateau
- Do not take extra Wegovy or shorten the interval between doses.
- Do not combine Wegovy with another GLP-1 medicine or another semaglutide product unless a prescriber has specifically told you to.
- Do not use laxatives, diuretics, vomiting, starvation dieting or excessive exercise to force the scale down.
- Do not ignore persistent vomiting, severe abdominal pain, dehydration symptoms or sudden vision changes.
- Do not stop and restart repeatedly without advice. Semaglutide has a long half-life and can remain in circulation for several weeks after the last dose. [2]
When to speak to your prescriber
Arrange a Wegovy review if you have had no meaningful change in your four-week trend, if you are regaining weight, if you feel hungry most of the time, if side effects are changing what you can eat, or if you are unsure whether your current dose is right. A clinician can check whether the issue is dose stage, tolerability, missed doses, diet structure, activity, another medicine, a health condition, or whether another plan is more appropriate.
If you have been unable to lose at least 5% of your initial body weight after six months on treatment, UK product information says a decision is required on whether to continue, taking account of the individual benefit–risk profile. NICE also advises clinicians to consider stopping semaglutide below this response threshold. [2,3]
